Chronic lymphocytic leukemia (CLL) is the most common leukemia in adults in the Western world. In spite of recent immunophenotypic, cytogenetic and molecular advances in the characterization of CLL, the oncogenic and cellular pathways are still poorly understood. A monoclonal B-cell lymphocytosis (MBL) could represent, in a proportion of cases, an early stage of CLL, [1] [2] [3] and an increased prevalence of MBL in first-degree relatives (FDR) of familial CLL compared to the general population has been reported. 4, 5 In order to study MBL as the early precursor of CLL, we investigated peripheral blood from the unaffected FDR of familial CLL, using high-sensitivity, multicolor flow cytometry (MCFCM) techniques, that is, sevencolor, nine parameters.
We studied six unaffected FDR and one affected individual from four CLL families ( Figure 1) ; four sporadic CLL patients and five blood bank donors were used as controls. Each of the six siblings had normal physical examinations, CBC and chemistry profiles. Median age of the FDR and of the normal donors was 51 years, (44-69) and (37-62), respectively. Seven-color, nineparameters flow cytometry allowed detection and analysis of very small and rare B-cell subsets. The lymphocyte sum was first established (CD45, CD14, CD19, CD3, CD4, CD8, CD16 þ 56). A sequential gating strategy was used for identifying B cells (lymphocyte scatter, CD19, CD20); we analyzed B-cell clonality (in terms of kappa or lambda light chain restriction), the differentiation pattern (CD27, IgM, IgD) and some activation markers (CD38, CD69), as well as the expression of CD5 and CD23 in each tube.
In five out of six FDR (individual B, pedigree 2; individuals C and D, pedigree 4; individual E, pedigree 10; individual G, pedigree 4573), we could identify a small subset representing 573.7% of the B cells (ie, 13 cells/ml), characterized by lambda light-chain restriction with almost no expression of CD20 (CD20À/dim). These cells expressed IgD in the absence of IgM ('IgD only'). The complete immunophenotype was CD20À/dim, CD5 þ /bright, CD23À, lambda þ , IgDþ , IgMÀ, CD27 þ , CD38 þ and CD69À (Figure 2 top row) . A blood bank control is shown in the lower row of Figure 2 .
In two unaffected FDR ( Figure 1 , individual C, pedigree 4 and individual E, pedigree 10), a 'CLL-like' MBL was identified. In individual C, pedigree 4, this monoclonal CD20 dim CD5 þ population represented 75% of the B cells, that is, 337.5 cells/ml, and displayed the 'CLL-like' immunophenotype: CD20 dim, CD5 þ , CD23 þ , lambda dim, IgD þ moderate to dim, IgM dim, CD27 dim, CD38À, CD69 þ moderate to dim. In individual E, pedigree 10, we found the same population, except that light-chain restriction was indeterminate due to lowlevel expression. In these individuals, the IgD only subset coexisted with the 'CLL-like' clone ( Figure 3 ). In addition, in both individuals, the CD20 þ /bright B cells were polyclonal and contained the remaining normal B cells.
In one unaffected FDR (Figure 1 , individual A, pedigree 2), we found a 'non-CLL-like' MBL. Looking differentially at the CD19 dim and CD19 bright subsets led to the recognition of this subset: CD19 dim, CD20 þ , CD5À, CD23À, kappa restricted, IgD dim, IgM þ , CD27 þ /dim, CD38 þ and CD69 þ . In a previous report 4 , this individual had a small cluster of kappabearing cells, and single-cell PCR confirmed the presence of a single clone (unpublished observation).
The same MCFCM assay was performed in five blood bank donors. In addition to the major CD20 þ B-cell population, we identified a small CD20À subset representing as few as Figure 1 Pedigrees of FDR used in this study.
0.9370.2% of the whole B-cell population (ie, estimated 2 cells/ml), in normal peripheral blood. This CD20À subset displayed a homogeneous phenotype 'plasma cell precursor like': CD5À, CD23À, dim light chain with a polyclonal kappa/ lambda ratio, IgMÀ, IgDÀ, CD27 bright, CD38 þ and CD69À ( Figure 2 , lower row).
To further investigate the immunophenotypic evolution in CLL, we studied four CLL samples with MCFCM, four sporadic and one familial. The CD20À, CD5 þ /bright, CD23À 'IgD only' subset described in the familial CLL FDR could not be detected in any of the sporadic CLL cases studied; however, it was seen in the affected familial CLL patient (individual F, pedigree 10).
The most striking result of this study is the finding of a CD19 þ , CD20À, CD5 þ bright, CD23À subset in five of six FDR. These B cells displayed a constant immunophenotype of lambda þ , IgD þ only (ie, IgMÀ), CD27 þ , CD38 þ , CD69À. They were identified in five out of six FDR, but in no case of normal donor peripheral blood (N ¼ 5). This peculiar immunophenotype IgD þ , IgMÀ, CD38 þ , lambda þ was previously described by Liu et al 6 in centroblasts localized within the dark zone of tonsilar germinal centers. These cells had undergone extensive somatic mutation with Cm-Cd switch, leading to the IgD þ only immunophenotype. They preferentially expressed the lambda light chain, whereas the expected kappa to lambda light chain ratio is 2 : 1.
6-8 Furthermore, even though lambda chain 'restriction' is prominent, single-cell PCR analysis reveals these hypermutated cells to be either oligoclonal or polyclonal. 8 In the original characterization of tonsillar IgD þ only B cells in normal individuals, the CD5, CD23, CD27 and CD69 expression was not described in the peripheral blood. In our study of peripheral blood, these cells are strikingly CD5 þ bright. In the present study, CD5 expression may reflect an aberrant phenotype, while the absence of expression of CD23 could correlate with a 'germinal center state of differentiation' and the expression of CD27 is expected with a hypermutated B cell. In normal individuals, these cells were initially identified in tonsils and were said not to be present in normal peripheral blood, a result consistent with our data in normal blood donors. We simultaneously identified the CLL-like MBL and IgD þ only cells in a father, and his daughter appeared to have inherited the IgD þ only cells. In a second pedigree, this IgD þ only subset was found in an affected CLL patient, and in the peripheral blood of her unaffected twin sister. This finding in FDR is highly significant as it may relate to the pathogenesis of CLL, that is, an early defect in apoptosis and/ or Ig gene editing. In addition, the identification of IgD only lambda þ B cells in FDR peripheral blood focuses on the potential importance of the germinal center in the CLL transformation.
In summary, using MCFCM, we identified IgD þ only lambda þ B cells in the peripheral blood of five out of six FDR from four different pedigrees. These cells were previously reported to only be in the germinal centers of normal donors. It will be of interest to confirm the presence of IgD þ only cells in other unaffected FDR and to determine its position in the sequence of events leading to neoplastic transformation. Longitudinal studies of these families combined with functional and molecular characterization of sorted cells will be required to establish the relationship between these potential precursors of CLL and to better understand the steps of malignant transformation in CLL. The characterization of an early marker of CLL transformation such as IgD þ only cells in the familial setting would permit the ascertainment of more informative families and assist linkage studies for the identification of susceptibility genes for CLL. 
